Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1984-08-09
1987-09-01
Warren, Charles F.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
424 85, 435 68, 43524027, 935104, 530809, A61K 39395, A61K 3516, C12N 500, C12P 2100
Patent
active
046910107
ABSTRACT:
Hybrid cell line for production of monoclonal antibody to an antigen found on approximately 10% of normal human thymocytes. The hybrid is formed by fusing splenocytes from immunized CAF.sub.1 mice with P3X63Ag8Ul myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
REFERENCES:
patent: 4364934 (1982-12-01), Kung et al.
patent: 4434156 (1984-02-01), Trowbridge
Goldstein Gideon
Kung Patrick C.
Dellenbaugh Geoffrey G.
Ortho Pharmaceutical Corporation
Tarcza John Edward
Warren Charles F.
LandOfFree
Hybrid cell line for producing monoclonal antibody to a human ea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid cell line for producing monoclonal antibody to a human ea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid cell line for producing monoclonal antibody to a human ea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1265663